Federated Hermes, Inc. Sc Pharmaceuticals Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $1,841 - $2,418	-206 Reduced 78.93%	55 $0
Q1 2023 May 08, 2023	BUY	$5.59 - $9.47 $1,458 - $2,471	261 New	261 $2,000
Q4 2020 Feb 12, 2021	SELL	$5.17 - $9.41 $449 - $818	-87 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.12 - $8.86 $1,196 - $1,488	-168 Reduced 65.88%	87 $1,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $1,787 - $2,794	255 New	255 $2,000
Q4 2019 Feb 14, 2020	SELL	$4.1 - $6.21 $172 - $260	-42 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.24 - $7.35 $136 - $308	42 New	42 $1,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.